Whether someone started at BMI 32 or BMI 48, whether they had diabetes or normal blood sugar, whether male or female, Retatrutide produced substantial weight reduction
Curr Treat Options Cardiovasc Med (2017) 19(3)
Together, these pathways make retatrutide one of the most promising future therapies for cardiometabolic health
You notice it most when you stop
In the SELECT trial, which included more than 17,000 patients with obesity and cardiovascular disease but not diabetes, semaglutide cut the rate of major cardiac events by 20%
These factors may include biological factors, such as lower testosterone and hormonal changes, mental and emotional issues, such as depression and other psychiatric illnesses, cultural issues, such as societal attitudes towards aging and older women, and interpersonal problems, such as relationship issues